시장보고서
상품코드
1184084

세계의 의약품 위탁연구생산(CRAM) 시장(2023-2027년)

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2023-2027

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 167 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

의약품 위탁연구생산(CRAM) 시장은 2022-2027년간 연평균 복합 성장률(CAGR)10.32%로 성장을 지속하여 1,213억 5,000만 달러 성장할 것으로 예측됩니다.

의약품 위탁연구생산(CRAM, Pharmaceutical Contract Research and Manufacturing) 시장 전체 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 정보를 제공합니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 : 2022년
  • 시장 전망 : 2022-2027년 예측

제4장 시장 규모 실적

  • 세계의 의약품 위탁연구생산(CRAM) 시장(2017-2021년)
  • 서비스 부문 분석(2017-2021년)
  • 최종사용자 부문 분석(2017-2021년)
  • 지역 부문 분석(2017-2021년)
  • 국가 부문 분석(2017-2021년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 서비스별 시장 세분화

  • 시장 부문
  • 서비스별 비교
  • CMO : 시장 규모와 예측(2022-2027년)
  • CRO : 시장 규모와 예측(2022-2027년)
  • 서비스별 시장 기회

제7장 최종사용자별 시장 세분화

  • 시장 부문
  • 최종사용자별 비교
  • 대형 의약품 : 시장 규모와 예측(2022-2027년)
  • 중소 의약품 : 시장 규모와 예측(2022-2027년)
  • 제네릭 의약품 : 시장 규모와 예측(2022-2027년)
  • 최종사용자별 시장 기회

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2022-2027년)
  • 아시아 : 시장 규모와 예측(2022-2027년)
  • 유럽 : 시장 규모와 예측(2022-2027년)
  • 기타 지역(ROW) : 시장 규모와 예측(2022-2027년)
  • 미국 : 시장 규모와 예측(2022-2027년)
  • 인도 : 시장 규모와 예측(2022-2027년)
  • 중국 : 시장 규모와 예측(2022-2027년)
  • 독일 : 시장 규모와 예측(2022-2027년)
  • 영국 : 시장 규모와 예측(2022-2027년)
  • 지역 상황별 시장 기회

제10장 시장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 시장 성장 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Cmic Holdings Co. Ltd.
  • Dr Reddys Laboratories Ltd.
  • ICON plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Lupin Ltd.
  • Recipharm AB
  • Samsung Electronics Co. Ltd.
  • Syneos Health Inc.

제13장 부록

LSH 23.01.20

Technavio has been monitoring the pharmaceutical contract research and manufacturing (CRAM) market and is forecast to grow by $ 121.35 bn during 2022-2027, accelerating at a CAGR of 10.32% during the forecast period. Our report on the pharmaceutical contract research and manufacturing (CRAM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets, the growing need to focus on core competencies, and strong research funding.

Technavio's pharmaceutical contract research and manufacturing (CRAM) market is segmented as below:

By Service

  • CMO
  • CRO

By End-user

  • Big pharmaceuticals
  • Small and medium-sized pharmaceuticals
  • Generic pharmaceuticals

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • Rest of World (ROW)

This study identifies the increasing number of us FDA-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract research and manufacturing (CRAM) market growth during the next few years. Also, the increasing number of patent expiration of drugs and the advent of big data will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the pharmaceutical contract research and manufacturing (CRAM) market covers the following areas:

  • Pharmaceutical contract research and manufacturing (CRAM) market sizing
  • Pharmaceutical contract research and manufacturing (CRAM) market forecast
  • Pharmaceutical contract research and manufacturing (CRAM) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract research and manufacturing (CRAM) market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Catalent Inc., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd., Dr Reddys Laboratories Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Recipharm AB, Samsung Electronics Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., PCI Pharma Services, Parexel International Corp., OPTIMAPHARM d.o.o., and Novotech Australia Pty Ltd. Also, the pharmaceutical contract research and manufacturing (CRAM) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
  • 4.2 Service Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
  • 4.3 End-user Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service

  • 6.1 Market segments
  • Exhibit 30: Chart on Service - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
  • 6.2 Comparison by Service
  • Exhibit 32: Chart on Comparison by Service
  • Exhibit 33: Data Table on Comparison by Service
  • 6.3 CMO - Market size and forecast 2022-2027
  • Exhibit 34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on CMO - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
  • 6.4 CRO - Market size and forecast 2022-2027
  • Exhibit 38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on CRO - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Service
  • Exhibit 42: Market opportunity by Service ($ billion)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
  • 7.2 Comparison by End-user
  • Exhibit 45: Chart on Comparison by End-user
  • Exhibit 46: Data Table on Comparison by End-user
  • 7.3 Big pharmaceuticals - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • 7.4 Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • 7.5 Generic pharmaceuticals - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by End-user
  • Exhibit 59: Market opportunity by End-user ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Asia - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.5 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 India - Market size and forecast 2022-2027
  • Exhibit 85: Chart on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 87: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 101: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 107: Matrix on vendor position and classification
  • 12.3 Almac Group Ltd.
  • Exhibit 108: Almac Group Ltd. - Overview
  • Exhibit 109: Almac Group Ltd. - Product / Service
  • Exhibit 110: Almac Group Ltd. - Key offerings
  • 12.4 Boehringer Ingelheim International GmbH
  • Exhibit 111: Boehringer Ingelheim International GmbH - Overview
  • Exhibit 112: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 113: Boehringer Ingelheim International GmbH - Key news
  • Exhibit 114: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 115: Boehringer Ingelheim International GmbH - Segment focus
  • 12.5 Cadila Pharmaceuticals Ltd.
  • Exhibit 116: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibit 117: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibit 118: Cadila Pharmaceuticals Ltd. - Key offerings
  • 12.6 Catalent Inc.
  • Exhibit 119: Catalent Inc. - Overview
  • Exhibit 120: Catalent Inc. - Business segments
  • Exhibit 121: Catalent Inc. - Key news
  • Exhibit 122: Catalent Inc. - Key offerings
  • Exhibit 123: Catalent Inc. - Segment focus
  • 12.7 Charles River Laboratories International Inc.
  • Exhibit 124: Charles River Laboratories International Inc. - Overview
  • Exhibit 125: Charles River Laboratories International Inc. - Business segments
  • Exhibit 126: Charles River Laboratories International Inc. - Key news
  • Exhibit 127: Charles River Laboratories International Inc. - Key offerings
  • Exhibit 128: Charles River Laboratories International Inc. - Segment focus
  • 12.8 Cmic Holdings Co. Ltd.
  • Exhibit 129: Cmic Holdings Co. Ltd. - Overview
  • Exhibit 130: Cmic Holdings Co. Ltd. - Business segments
  • Exhibit 131: Cmic Holdings Co. Ltd. - Key offerings
  • Exhibit 132: Cmic Holdings Co. Ltd. - Segment focus
  • 12.9 Dr Reddys Laboratories Ltd.
  • Exhibit 133: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus
  • 12.10 ICON plc
  • Exhibit 137: ICON plc - Overview
  • Exhibit 138: ICON plc - Product / Service
  • Exhibit 139: ICON plc - Key offerings
  • 12.11 IQVIA Holdings Inc.
  • Exhibit 140: IQVIA Holdings Inc. - Overview
  • Exhibit 141: IQVIA Holdings Inc. - Business segments
  • Exhibit 142: IQVIA Holdings Inc. - Key news
  • Exhibit 143: IQVIA Holdings Inc. - Key offerings
  • Exhibit 144: IQVIA Holdings Inc. - Segment focus
  • 12.12 Laboratory Corp. of America Holdings
  • Exhibit 145: Laboratory Corp. of America Holdings - Overview
  • Exhibit 146: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 147: Laboratory Corp. of America Holdings - Key news
  • Exhibit 148: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 149: Laboratory Corp. of America Holdings - Segment focus
  • 12.13 Lonza Group Ltd.
  • Exhibit 150: Lonza Group Ltd. - Overview
  • Exhibit 151: Lonza Group Ltd. - Business segments
  • Exhibit 152: Lonza Group Ltd. - Key news
  • Exhibit 153: Lonza Group Ltd. - Key offerings
  • Exhibit 154: Lonza Group Ltd. - Segment focus
  • 12.14 Lupin Ltd.
  • Exhibit 155: Lupin Ltd. - Overview
  • Exhibit 156: Lupin Ltd. - Product / Service
  • Exhibit 157: Lupin Ltd. - Key news
  • Exhibit 158: Lupin Ltd. - Key offerings
  • 12.15 Recipharm AB
  • Exhibit 159: Recipharm AB - Overview
  • Exhibit 160: Recipharm AB - Business segments
  • Exhibit 161: Recipharm AB - Key offerings
  • Exhibit 162: Recipharm AB - Segment focus
  • 12.16 Samsung Electronics Co. Ltd.
  • Exhibit 163: Samsung Electronics Co. Ltd. - Overview
  • Exhibit 164: Samsung Electronics Co. Ltd. - Business segments
  • Exhibit 165: Samsung Electronics Co. Ltd. - Key news
  • Exhibit 166: Samsung Electronics Co. Ltd. - Key offerings
  • Exhibit 167: Samsung Electronics Co. Ltd. - Segment focus
  • 12.17 Syneos Health Inc.
  • Exhibit 168: Syneos Health Inc. - Overview
  • Exhibit 169: Syneos Health Inc. - Business segments
  • Exhibit 170: Syneos Health Inc. - Key offerings
  • Exhibit 171: Syneos Health Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 172: Inclusions checklist
  • Exhibit 173: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 174: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 175: Research methodology
  • Exhibit 176: Validation techniques employed for market sizing
  • Exhibit 177: Information sources
  • 13.5 List of abbreviations
  • Exhibit 178: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제